Reply to 'Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status'

MLA

Ari Melnick, et al. “Reply to ‘Uveal Melanoma Cells Are Resistant to EZH2 Inhibition Regardless of BAP1 Status.’” Nature Medicine, vol. 22, no. 6, June 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34ddf48b92403fd39685d65f8df92e4d&authtype=sso&custid=ns315887.

APA

Ari Melnick, Alan Chramiec, Ouathek Ouerfelli, Benjamin H. Durham, Prasad S. Adusumilli, Neil L. Kelleher, Todd Hricik, Barbara Spitzer, Xinxu Shi, Paul M. Thomas, Ross L. Levine, Elisa de Stanchina, Katerina Konstantinoff, Matt Teater, Richard Koche, Scott A. Armstrong, Matthew D. Keller, John Campbell, Gil Blum, … Jean Baptiste Micol. (2016). Reply to “Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status.” Nature Medicine, 22(6).

Chicago

Ari Melnick, Alan Chramiec, Ouathek Ouerfelli, Benjamin H. Durham, Prasad S. Adusumilli, Neil L. Kelleher, Todd Hricik, et al. 2016. “Reply to ‘Uveal Melanoma Cells Are Resistant to EZH2 Inhibition Regardless of BAP1 Status.’” Nature Medicine 22 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....34ddf48b92403fd39685d65f8df92e4d&authtype=sso&custid=ns315887.